Moderna COVID-19 Vaccine Passes Phase 1: What’s Next?

<p>On July 14, 2020, NEJM published the results of Phase 1, dose-escalation, open-label trial of the ModeRNA vaccine. Its technology-enabled ModeRNA to speed up the process, bypassing and shaving the typical steps involved in vaccine development.</p><p>For more information, contact us at 859-721-1414 or myhealth@prevmedheartrisk.com. Also, check out the following resources:  </p><p>·<a href="https://prevmedhealth.com/" target="_blank">PrevMed's website</a></p><p>·<a href="https://www.youtube.com/channel/UCmoEsq6a6ePXxgZeA4CVrUw" target="_blank">PrevMed's YouTube channel</a></p><p>·<a href="https://www.facebook.com/PrevMedHeartRisk" target="_blank">PrevMed's Facebook page</a></p>